Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2014, Vol 2, Issue 4
Abstract
Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrospective review of patients with neovascular ARMD, who were switched from treatment with Pro Re Nata (PRN) IVB to PRN IVR, was conducted in a university clinic. IVB (1.25 mg/0.05 ml) and IVR (0.5 mg/0.05 ml) were used. Retreatment criteria were defined based on an activity scoring (AS) system developed in our clinic. An AS was calculated for each lesion at each visit. AS results and the number of injections before and after switching treatment to IVR were compared.
Authors and Affiliations
Nilay Yuksel
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells
Ultrastructural Characterization of a Developing Pericytic Microtumor in the White Matter Post Laceration
We studied by transmission electron microscopy an intraparenchymatous mass within white matter found in a patient operated on for cerebral laceration. According to the ultrastructural criteria, this mass was diagnosed as...
Relationship Between Stem Cell Pluripotency And Physical Activity Levels In Office Workers: Rationale And Study Design For The Stand Up Stem Cells (SUSC) Randomized Trial
Background: Excessive time spent in sedentary behaviours (sitting or lying with low energy expenditure) is associated with an increased risk for type 2 diabetes, cardiovascular disease and some cancers. Desk-based office...
Photo Documentation In Ocular Trauma
Objective: Aim of the study is to photograph different cases of ocular trauma to ensure the safety of an ophthalmologist in giving prognosis and avoiding problems which are faced in court of law in criminal cases. Study...
Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review
Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, development of immunosuppressive agents is the key for successful allograft function. Immunosuppression agents in RT have evolv...